September 8, 2021
Genetic variants influence migraine treatment response, according to new Mayo study
By Susan Murphy
Migraines affect nearly 40 million people in the U.S. Yet pinpointing an effective prophylactic medication ― the most commonly prescribed drugs for people diagnosed with migraines ― remains a long and complex process. Patients often cycle through medications for weeks or months until achieving a therapeutic response. Now after years of slow progress in migraine therapies […]
Tags: Center for Individualized Medicine, Fred Cutrer, genetics, migraine, neurology, personalized medicine, pharmacogenomics, Richard Weinshilboum
July 28, 2021
Opioids provide low evidence of pain relief for migraine, large Mayo analysis finds
Evidence that opioids provide pain relief for migraine headaches is low or insufficient, a large Mayo Clinic meta-analysis published recently in JAMA has found. However, some newer therapies, along with established migraine treatments, were associated with moderate to high evidence of pain relief. The meta-analysis – which combined results from multiple scientific studies – included […]
Tags: Center for the Science of Health Care Delivery, headache, Juliana VanderPluym, migraine, opioids, Zhen Wang
June 21, 2021
Mayo Clinic Research in the news — 6/21/2021
By Advancing the Science contributor
Mayo Clinic research and faculty experts were in the news this week on managing life after COVID-19 and vaccine-related questions, as well as migraine, hiccups, the state of HIV research and more. Nervous about resuming activities? How to manage ‘COVID transition anxiety’ Star Tribune, 6/17/2021 We asked Reese Druckenmiller, a therapist with Mayo Clinic Health […]
Tags: Andrew Badley, animal model, arthritis, artificial intelligence, Ashima Makol, breast cancer, cancer, cardiology, cost of care, COVID-19, David Dodick, David Nestler
June 14, 2021
Mayo Clinic Research in the news — 6/14/2021
By Advancing the Science contributor
Read on for news of the week that includes Mayo Clinic Research and research experts. Topics include a new Alzheimer’s medication, COVID-19, and various regenerative medicine innovations. US approves first new Alzheimer’s drug in 20 years BBC, 6/8/2021 A controversial drug to treat Alzheimer’s disease has been approved by the Food and Drug Administration in […]
Tags: aging, Alzheimer's disease, Andre Terzic, animal model, biomedical ethics, brain, BRCA1, breast cancer, cancer, Center for Regenerative Medicine, Cheryl Willman, concussion
May 24, 2021
Mayo Clinic research in the news — 5/24/2021
By Advancing the Science contributor
As we settle into the second year of the pandemic, and immunization efforts are well underway, the focus on health and medical research seems to be settling into a broader spectrum. Read on for news reports with Mayo Clinic research and faculty members, covering BPAs, Reynaud’s, C. diff., and some personal achievements, among other topics. […]
Tags: Andrew Badley, Anna Carrano, biomedical research, Brent Bauer, C. diff, cardiology, Cheryl Willman, clinical trials, COVID-19, education, Gregory Poland, Illana Breen
April 19, 2021
Mayo Clinic Research in the news — 4/19/2021
This week saw some advances in neurology for patients with memory loss or Parkinson’s disease, as well as furthered understanding of the role race plays in personalized medicine. Read about these, updates on COVID-19, and a number of other findings in health care and biomedical research. Blood-Based Markers Tied to Brain Cell and Memory Loss […]
Tags: acute kidney injury, Amaal Starling, artificial intelligence, brain cancer, brain tumor, chronic kidney disease, clinical trials, cognitive impairment, concussion, COVID-19, Cumara O'Carroll, diversity
March 8, 2021
Mayo Clinic Research in the news — 3/8/2021
By Advancing the Science contributor
In Mayo Clinic research news over the past seven days, the headlines covered medical marijuana, systemic racism, Alzheimer’s, and a range of other topics including COVID-19. Minnesota Senate bill could increase spinal cord research funding, KSTP, 3/4/2021 This $285 eye scan may someday detect Alzheimer’s risk. (It also requires plenty of curry flavoring.), Advisory Board, […]
Tags: ADHD, aging, Alzheimer's disease, biomarkers, cholesterol, clinical trials, colorectal cancer, COVID-19, dementia, health care systems engineering, health disparities, lymphoma
February 1, 2021
Mayo Clinic Research in the news — 2/1/2021
Mayo Clinic faculty continue to share their expertise across a broad range of medical and health care topics, including women’s health, concussion, disparities in care, and the never abating COVID-19. Mayo Clinic Indicates Age Has Distinct Influences on Sex-Related Outcomes After Heart Attack Pharmacy Times, 1/27/2021 Researchers at the Mayo Clinic have found ways that […]
Tags: Alex Adjei, Ali Duarte Garcia, breast cancer, CAR-T cell therapy, Centers for Disease Control and Prevention, concussion, COVID-19, depression, diabetes, drug discovery, gene mutation, Grzegorz Nowakowski